Xu R. Response to the letter titled reply to "Associations of semaglutide with
first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes:
Target trial emulation using nationwide real-world data in the US". Alzheimers Dement 2025;21:e14611.
PMID: 39950490
|